Page Title

Advancing Access is a patient support program that can provide information on coverage and financial support options for individuals who have been prescribed a Gilead HIV treatment, HIV prevention, or COVID-19 medication.

• Co-pay coupon card
• Patient Assistance Program/Medication Assistance Program (PAP/MAP)
• Benefits investigations
• Prior authorization and appeals process information
• Information on additional support and coverage options

Advancing Access program specialists can conduct a benefits investigation to help you and your patient understand their insurance coverage and any prior authorization or appeals process requirements. In Support Offerings and Resources, you will find sample letters of medical necessity and appeal, as well as a prior authorization checklist and claim forms.

If you or your staff would like to learn more about the Advancing Access program and the program support available to your patients, please call the program at 1-800-226-2056 to set up a training webinar.

• To enroll a patient in Advancing Access, you may use the HCP portal.
  • Go to the online enrollment portal and follow the on-screen instructions for enrolling a patient
  • By using the online enrollment portal, you can request assistance with a benefits investigation, submit an e-prescription and electronic prior authorization, or receive an immediate determination of your patient’s eligibility for the Patient Assistance Program/Medication Assistance Program (PAP/MAP)
• You can also fax an enrollment form, typically reviewed within 2 business days. The completed enrollment form should be faxed to the number on the form. Choose your patient’s enrollment form:
  • Advancing Access Program Enrollment Form (English)
  • Advancing Access Program Enrollment Form (Spanish)
  • SUNLENCA® (lenacapavir) Program Enrollment Form (English)
• You can also call Advancing Access at 1-800-226-2056 to speak with a program specialist

To register, go to https://advancingaccess.iassist.com/register and follow the steps. If you need help registering, please call the iAssist helpdesk at 1-877-450-4412 for assistance.

All required sections of the enrollment form, along with your signature and your patient’s signature, are required to be completed.

Advancing Access will send a fax to your office letting you know if your patient was eligible for PAP/MAP. Additionally, we will let your patient know via their preferred communication method listed on their enrollment form.

The Gilead Advancing Access Patient Assistance Program (PAP) provides prescribed HIV treatment and COVID-19 medications free of charge to eligible individuals.

The Gilead Advancing Access Medication Assistance Program (MAP) provides prescribed HIV prevention medication free of charge to eligible individuals.

Advancing Access will notify you and your patient if they were eligible based on the preferred communication method your patient listed on the enrollment form.

To be eligible to enroll into PAP/MAP, individuals need to be residents of the United States, Puerto Rico, or US Territories, in addition to meeting other eligibility criteria. Proof of residency may be required.

Standard PAP/MAP enrollment is for up to 12 months, pending ongoing eligibility checks.

If there is ongoing need for support and the patient remains eligible for PAP/MAP, then they can re-enroll.

Advancing Access will reach out to you and your patient 60 days prior to the enrollment end date.

There are several ways to re-enroll eligible individuals into PAP/MAP. You can fax in a new enrollment form or, if you are a registered user of the online enrollment portal, you may be able to re-enroll eligible individuals electronically.

Many individuals who need ongoing PAP/MAP support can be re-enrolled through the online enrollment portal. Follow these steps:

1. Log in to the portal as you normally would
2. On the HOME screen, click on DRAFTS - located in the panel on the left side of the screen
3. Once in the drafts section, click on Re-Verification Drafts. Select or search for specific individual
4. Click on the appropriate individual. You will be routed to the re-enrollment service offering

If you have questions about using this process, please call an Advancing Access program specialist at 1-800-226-2056.

Generally speaking, PAP/MAP is for eligible uninsured individuals without access to additional support and coverage options for obtaining their medication. If your patient is eligible for Medicaid or the AIDS Drug Assistance Program (ADAP), they may not be eligible to re-enroll in PAP/MAP. Please have your patient call Advancing Access to see if they may be able to re-enroll in PAP/MAP.

Please notify Advancing Access by calling 1-800-226-2056 to have the individual withdrawn from PAP/MAP.

• You can use the online enrollment portal, which will give you an immediate determination of an individual’s PAP/MAP eligibility
• You can fax a completed enrollment form to the number on the form. All faxed enrollment forms are reviewed in the order they are received, and you will be notified within 2 business days with a determination of eligibility. Choose your enrollment form:
  • Advancing Access Program Enrollment Form (English)
  • Advancing Access Program Enrollment Form (Spanish)
  • SUNLENCA® (lenacapavir) Program Enrollment Form (English)
• Or, if there is an urgent need to get your patient started, please call an Advancing Access program specialist at 1-800-226-2056

Your patient can fill their PAP/MAP prescription at any participating retail pharmacy. Please use the Pharmacy Finder to locate a participating pharmacy. Additionally, Advancing Access offers a mail order option for patients, where the product can be delivered to your patient’s home or to an alternate address of their choice.

There are over 40,000 participating retail pharmacies. While using the Pharmacy Finder, enter the pharmacy name and ZIP code to see if the patient’s pharmacy participates in PAP/MAP. If they don’t already have a pharmacy, they can enter their ZIP code to find participating pharmacies near them.

If your patient would like their medication sent directly to them, they can select “mail order delivery” while filling out the enrollment form. Your patient can also call Advancing Access at 1-800-226-2056 for assistance.

The Gilead Co-pay Coupon Card may help eligible, commercially insured individuals lower their out-of-pocket (OOP) costs. It is not available to your patient if they are enrolled in any federally or state-funded prescription drug program, such as Medicare, Medicare Part D, or Medicaid. For more information and to see if your patient is eligible, view co-pay program benefits and terms and conditions.

Your patient can go to the co-pay program page to enroll.

The coverage amount varies depending on the medication. For the most up-to-date amounts, view co-pay program benefits and terms and conditions.

No, the co-pay coupon card does not expire. Once your patient is enrolled in the co-pay program, your patient keeps the same card for the duration of their enrollment in the program. For information about the annual coverage amount for the co-pay program, please visit the co-pay program page.

The patient can go to Replace a Card on the co-pay program page. If help is still needed, the patient can call an Advancing Access program specialist at 1-800-226-2056.

If the patient has not yet activated that card, the patient can go to Enroll on the co-pay program page. If the patient had already activated the card but lost it, the patient should select Replace to retrieve card information. If help is still needed, call an Advancing Access program specialist at 1-800-226-2056.

If a patient is prescribed a different Gilead HIV treatment or HIV prevention medication, they can continue to use the same card for the new medication. However, SUNLENCA® (lenacapavir) has its own specific co-pay cards for which the patient must enroll separately.